This is the April 2016 newsletter from the RespiTech Group at the Woolcock Institute of Medical Research. During April the team attended Respiratory Drug Delivery in Arizona. Daniela, Paul, YY, Larissa and Michele presented an update of research from the group. The group had 4 peer reviewed full-conference abstracts accepted for publication. In addition, Larissa Gomes was invited to give a poster on the podium presentation on her work in respiratory vaccine drug delivery space, while Paul gave a podium presentation on the mysteries of lactose and the meaning of life.
Back at home the group celebrated Yang Chen’s PhD graduation -Well done Dr Yang! We also said farewell to Marie Hellfritzsch, who returns to the University of Kiel after spending the past few months with our group working on a collaborative project in the area of nano-technology. You can learn more about the social aspects of the RespiTech group via our Facebook page or Twitter pages.
As always, the group give an update of their publications. This month the group had one publication accepted in the International Journal of Pharmaceutics entitled ‘The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis.’ Details of this publication along with all others from the RespiTech group can be found on our publications page.